- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 144-158 of
1,041 results
No. 96
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 96 (E.D.Tex. Feb. 18, 2016)
|
|
Cite Document
125 Other: Patent Owners Supplemental Brief on Litigation Waiver
Document
IPR2016-01130, No. 125 Other - Patent Owners Supplemental Brief on Litigation Waiver (P.T.A.B. Jan. 12, 2018)
|
|
Cite Document
No. 182
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 182 (E.D.Tex. Sep. 2, 2016)
|
|
Cite Document
123 Other: Petitioners Supplemental Brief on Litigation Waiver
Document
IPR2016-01130, No. 123 Other - Petitioners Supplemental Brief on Litigation Waiver (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
119 Response: Petitioners Response After Amicus Briefing
Document
IPR2016-01130, No. 119 Response - Petitioners Response After Amicus Briefing (P.T.A.B. Dec. 15, 2017)
|
|
Cite Document
4 Notice of Filing Date Accorded to Petition: Notice of Filing Date Accorded to Petitio...
Document
IPR2016-01130, No. 4 Notice of Filing Date Accorded to Petition - Notice of Filing Date Accorded to Petition and Time for Filing Patent Owner Preliminary Reponse (P.T.A.B. Jun. 9, 2016)
|
|
Cite Document
11 Motion: Motion for Pro Hac Vice Peter J Curtin
Document
IPR2017-00568, No. 11 Motion - Motion for Pro Hac Vice Peter J Curtin (P.T.A.B. Mar. 27, 2017)
|
|
Cite Document
10 Reply: Petitioners Reply Motion For Joinder
Document
IPR2017-00568, No. 10 Reply - Petitioners Reply Motion For Joinder (P.T.A.B. Mar. 6, 2017)
|
|
Cite Document
No. 546-1
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 546-1 (E.D.Tex. Nov. 20, 2017)
|
|
Cite Document
No. 541-1
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-1 (E.D.Tex. Nov. 13, 2017)
|
|
Cite Document
No. 541-2
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-2 (E.D.Tex. Nov. 13, 2017)
|
|
Cite Document
No. 541-3
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-3 (E.D.Tex. Nov. 13, 2017)
|
|
Cite Document
No. 536-2
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-2 (E.D.Tex. Nov. 6, 2017)
|
|
Cite Document
No. 536-4
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-4 (E.D.Tex. Nov. 6, 2017)
|
|
Cite Document
No. 536-3
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-3 (E.D.Tex. Nov. 6, 2017)
|
|
Cite Document
